The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Talquetamab (tal) + daratumumab (dara) in patients (pts) with relapsed/refractory multiple myeloma (RRMM): Updated TRIMM-2 results.
 
Bhagirathbhai R. Dholaria
Stock and Other Ownership Interests - Iovance Biotherapeutics; Syndax
Honoraria - Adaptive Biotechnologies; Curio Science; MJH Healthcare Holdings, LLC; Wiley
Consulting or Advisory Role - arivan research; Beam Therapeutics; Gamida Cell; Jazz Pharmaceuticals; Pluristem Therapeutics
Research Funding - Angiocrine Bioscience (Inst); Janssen Oncology (Inst); MEI Pharma (Inst); Orca Bio (Inst); Pfizer (Inst); poseida therapeutics (Inst); Takeda (Inst); WUGEN, Inc. (Inst)
 
Katja Weisel
Honoraria - Abbvie; Adaptive Biotechnologies; Amgen; Amgen (Inst); Bristol-Myers Squibb; Bristol-Myers Squibb/Celgene (Inst); Celgene; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline (Inst); Janssen (Inst); Janssen-Cilag; Karyopharm Therapeutics; Novartis; Oncopeptides; Pfizer; Roche; Sanofi; Sanofi (Inst); Takeda
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen-Cilag; Karyopharm Therapeutics; Oncopeptides; Roche; Sanofi; Takeda
Research Funding - Amgen (Inst); Bristol-Myers Squibb/Celgene (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Janssen-Cilag (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen-Cilag; Takeda
 
Maria-Victoria Mateos
Honoraria - Abbvie/Genentech; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Pfizer; Regeneron; Roche/Genentech; Takeda
 
Hartmut Goldschmidt
Honoraria - Amgen; Bristol-Myers Squibb; Chugai Pharma; GlaxoSmithKline; Janssen-Cilag; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Adaptive Biotechnologies (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Janssen-Cilag (Inst); Sanofi (Inst)
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); GlaxoSmithKline (Inst); GlycoMimetics Inc. (Inst); Heidelberg Pharma (Inst); Incyte (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Millenium Pharamceuticals (Inst); Molecular Partners (Inst); MorphoSys (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen-Cilag; Novartis; Pfizer; Sanofi
Other Relationship - Amgen (Inst); Array BioPharma/Pfizer (Inst); Celgene/Bristol-Myers Squibb (Inst); Chugai Pharma Europe (Inst); Janssen (Inst); Mundipharma (Inst); Sanofi (Inst)
 
Thomas G. Martin
Consulting or Advisory Role - GlaxoSmithKline; Legend Biotech
Research Funding - AMGEN (Inst); Janssen Oncology (Inst); Sanofi (Inst)
 
Daniel Morillo
Honoraria - Abbvie; Takeda
Travel, Accommodations, Expenses - Janssen Oncology
 
Donna Ellen Reece
Honoraria - Amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Sanofi; Takeda
Consulting or Advisory Role - Janssen
Research Funding - Bristol-Myers Squibb; Janssen
 
Paula Rodríguez-Otero
Honoraria - Abbvie; Celgene; GlaxoSmithKline; H3 Biomedicine; Janssen; Pfizer; Sanofi
Consulting or Advisory Role - Abbvie; BMS; GlaxoSmithKline; Janssen; Pfizer; Sanofi
Speakers' Bureau - BMS; GlaxoSmithKline; Janssen; Sanofi
Travel, Accommodations, Expenses - Pfizer
 
Manisha Bhutani
Research Funding - Adaptive Biotechnologies (Inst); Amgen (Inst); Bluebird Bio (Inst); Bristol-Myers Squibb/Celgene (Inst); Celularity Inc. (Inst); Cerecor (Inst); Janssen Research & Development (Inst); Legend Biotech (Inst); MedImmune (Inst); Takeda (Inst)
 
Anita D'Souza
Consulting or Advisory Role - Akcea Therapeutics; Bristol-Myers Squibb/Celgene; Janssen Oncology; Pfizer; Prothena
Research Funding - Abbvie (Inst); Caelum Biosciences (Inst); Janssen Oncology (Inst); Prothena (Inst); Regeneron (Inst); Sanofi (Inst); Sorrento Therapeutics (Inst); Takeda (Inst); TeneoBio (Inst)
Travel, Accommodations, Expenses - Imbrium Therapeutics
 
Albert Oriol
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Sanofi
Speakers' Bureau - Amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Sanofi
 
Laura Rosiñol
Honoraria - Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen-Cilag; Sanofi
 
Nizar J. Bahlis
Honoraria - Abbvie; Amgen; Celgene; Genentech/Roche; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen; Karyopharm Therapeutics; Pfizer; Sanofi; Takeda
Research Funding - Celgene (Inst); Janssen (Inst)
 
Kalpana Bakshi
Employment - GlaxoSmithKline; Janssen
Stock and Other Ownership Interests - GlaxoSmithKline; Janssen
 
Lijuan Kang
Employment - Janssen; Merck (I)
Stock and Other Ownership Interests - Janssen; Merck (I)
 
Lien Vandenberk
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
 
Marie-Anne Damiette Smit
Employment - Amgen; Janssen Biologics BV; Johnson & Johnson
Stock and Other Ownership Interests - Amgen; Johnson & Johnson
 
Ralph Wäsch
Honoraria - Abbvie; Amgen (Inst); Bristol-Myers Squibb/Celgene (Inst); Janssen (Inst); Kite/Gilead (Inst); Pfizer (Inst); Sanofi (Inst)
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); Bristol-Myers Squibb/Celgene (Inst); Janssen (Inst); Kite/Gilead (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)
Research Funding - Janssen (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Celgene; Gilead Sciences; Janssen
 
Niels W.C.J. van de Donk
Consulting or Advisory Role - Adaptive Biotechnologies (Inst); Amgen (Inst); Bayer (Inst); Bristol Myers Squibb Foundation (Inst); Celgene (Inst); Janssen (Inst); Novartis (Inst); Roche (Inst); SERVIER (Inst); Takeda (Inst)
Research Funding - Amgen (Inst); Bristol Myers Squibb Foundation (Inst); Celgene (Inst); Cellectis (Inst); Janssen (Inst); Novartis (Inst)
 
Ajai Chari
Consulting or Advisory Role - Abbvie; Amgen; Antengene; Bristol-Myers Squibb/Celgene; Genentech; Genzyme; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; OncoPeptides; Seagen; Secura Bio; Shattuck Labs; Takeda
Research Funding - Amgen; Celgene; Janssen; Pharmacyclics; Seagen; Takeda